Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on May 15, 2024 9:15am
113 Views
Post# 36040767

RE:CC

RE:CC
Romulus22 wrote: Just one caller. Disappointing, no more opportunity to get 'colour'

.. Will the company get some of this out to the public or we all wait till next CC? Is it just me or do they downplay their strides and successes.


Not the best call on a bunch of fronts.  And it shouldn't be on the 'analysts' to drag information out of the company, rather, it should be the company offering up tangible forward looking guidance.  In this case, the call was esentially more of the same.  I don't think they're downplaying their successes, I just think that positive trending isn't worthy of a ticker tape parade and it seems as if that this is their perspective as well.  Running a sustaintable business is hard, especially in the weed sector, but LABS won't get any love for simply running a sustainable business I'm afraid. 

Too much secrecy around 'partners' and not enough tangible facts around those partners and what they're doing with them.

Certainly don't like that there is no fixed profitability guidance either and that they still seem fixated on M&A rather than a share buyback to increase SP/value.  The carcasses will still be there so a near term buyback to give your shareholders some love would go a long way to get noticed.  As I've said before, if LABS can't grow and make big money with what they have now, in the tail wind environment that now exists, bolting on another broken business or two won't win the day either.
<< Previous
Bullboard Posts
Next >>